CBD flowers don't get you high. Cannabidiol binds only very weakly to the CB1 receptor in the brain, which is the receptor through which THC produces its intoxicating effect. That's the key difference, and it's well documented pharmacologically. Everything else about the effects of CBD flowers is far less clear-cut than a lot of marketing copy suggests: clinical research works almost exclusively with isolated cannabidiol in high doses, given as a capsule or solution. A dried flower, by contrast, delivers a mixture of several cannabinoids and terpenes in much smaller amounts, and for this specific form of intake there's hardly any controlled data.
How do CBD flowers work?
Cannabidiol acts on several target structures in the body, including the endocannabinoid system, the serotonin receptor 5-HT1A, and the ion channel TRPV1. The endocannabinoid system consists of receptors and the body's own messenger substances and is involved in regulating pain perception, appetite, sleep, and immune responses. THC docks there directly as a partial agonist at the CB1 receptor. Cannabidiol barely does this and instead acts in a modulating way. Most of these findings come from cell and animal models, not from controlled studies in humans.
There's another difference between the pure substance and the plant. A flower contains, alongside CBD, smaller amounts of cannabigerol and cannabichromene as well as terpenes like myrcene, limonene, or pinene. There are also strains specifically bred for a different cannabinoid, such as the CBG flower Orange Skunk. The idea that such a mixture works differently than isolated cannabidiol is called the entourage hypothesis. Ethan Russo discussed it at length in 2019 in Frontiers in Plant Science, while also noting that solid clinical evidence is lacking. The hypothesis is plausible. It hasn't been proven to this day.
One example of the gap between lab and everyday use: a Harlequin flower is described by its terpene profile and CBD content. The strain description says nothing about how these substances interact in the body.
What doses have been studied in CBD research?
The most meaningful data come from epilepsy research and work with amounts far higher than what's found in a flower. Epidyolex, approved in the EU since 2019, contains highly purified cannabidiol and has been studied at daily doses of 10 to 20 milligrams per kilogram of body weight. For an adult weighing 70 kilograms, that's 700 to 1,400 milligrams a day. A CBD flower with several percent cannabidiol contains a double-digit milligram amount per gram. The orders of magnitude compared directly:
| Form | Cannabidiol content | Context |
|---|---|---|
| Epidyolex, study dose | 10 to 20 mg per kg body weight daily | 700 to 1,400 mg for a 70 kg adult, highly purified CBD |
| CBD flower, 5 percent | around 50 mg per gram of flower material | raw material, only part of which enters the bloodstream |
| CBD flower, 10 percent | around 100 mg per gram of flower material | plus CBG, CBC, and terpenes in the mix |
When it comes to the frequently cited studies on sleep and tension, the evidence gets thinner. The case series by Shannon and colleagues in The Permanente Journal followed 72 adults over three months, without a control group and without blinding. The authors themselves describe the design as preliminary. Suraev and colleagues concluded in a 2020 review in Sleep Medicine Reviews (PubMed ID 32428841) that the evidence isn't sufficient for general recommendations.
There's an additional methodological problem that rarely comes up in studies but constantly does in retail: nobody inhales a dried flower of unknown composition in a lab. Values from a capsule containing 300 milligrams of CBD therefore can't be transferred to a gram of flower material.
CBD flower effects compared to THC
THC alters perception, sense of time, and coordination, while CBD, as far as we currently know, doesn't. The WHO Expert Committee on Drug Dependence stated in its 2018 Critical Review Report on cannabidiol that CBD shows no evidence of abuse or dependence potential in humans and is generally well tolerated. The same doesn't apply to THC: acute impairments and, with regular use, a risk of dependence are documented.
| Parameter | CBD | THC |
|---|---|---|
| Binding at the CB1 receptor | very weak, acts more as a modulator | partial agonist, direct activation |
| Intoxicating effect | not described | alters perception, sense of time, coordination |
| Dependence potential | according to the 2018 WHO report, no evidence in humans | documented with regular use |
| Detection in standard drug tests | tests don't react to cannabidiol | breakdown products are the target of the tests |
| Limit in hemp | not limited | maximum 0.3 percent under § 1 No. 9 KCanG |
The legal framework follows this distinction. Hemp is defined in § 1 No. 9 KCanG as having a THC content of no more than 0.3 percent. A hemp flower isn't therefore completely THC-free. If you regularly undergo drug tests at work or in traffic, you should be aware of these residual amounts. You can read how the rules have developed since the Cannabis Act in our article on the legal status of CBD flowers.
In practical terms, this means: two flowers can look identical, and only an analysis of the cannabinoid profile reveals whether one of them falls under the 0.3 percent limit.
How long do CBD flowers work?
After inhalation, the effect sets in within minutes, while elimination from the body takes place over several days. Millar and colleagues compiled the pharmacokinetic data on cannabidiol in humans in 2018 in Frontiers in Pharmacology. The most important figures from this review:
| Route of intake | Bioavailability | Half-life |
|---|---|---|
| Smoking | around 31 percent | about 31 hours |
| Oral, repeated dosing | around 6 percent in older studies | two to five days |
Half-life and perceived effect are two different things. The fact that CBD is still detectable in the blood doesn't mean the subjectively perceived relaxation lasts that long. User reports on inhaled intake usually mention two to four hours, though this range hasn't been verified. High-fat meals measurably increase the absorption of oral CBD, which makes comparisons even harder.
A practical example from lab results: if you take CBD over several consecutive days, the substance accumulates in fatty tissue, which means measurements on day five can turn out higher than on day one.
Side effects of CBD flowers
The documented side effects are mainly fatigue, diarrhea, loss of appetite, and altered liver values, observed in studies using high doses. These side effects come from approval studies on pure cannabidiol, in which daily amounts in the gram range were used. Cannabidiol also inhibits liver enzymes of the cytochrome P450 family, including CYP3A4 and CYP2C19. This can raise blood levels of other active substances, a known example being the antiepileptic drug clobazam.
If you take medication regularly, talk to your doctor about how to handle cannabidiol-containing products. Interactions via liver enzymes aren't a theoretical risk.
A second point concerns not the cannabinoid but the combustion process. Any smoke from burning plant material contains carbon monoxide, tar, and polycyclic aromatic hydrocarbons. This exposure happens regardless of whether the flower contains THC or CBD. In retail, CBD flowers are therefore sold as aroma products, and the information on product pages refers to strain, scent, and cannabinoid content, not to a method of consumption.
Does the effect depend on the flower's cannabinoid content?
The declared CBD content determines how much cannabidiol is actually present in the material, and it varies considerably between strains and batches. Cannabinoids and terpenes are produced in the trichomes, the sticky glandular heads on flowers and small leaves. A dense resin layer is linked to harvest timing and drying and serves as a rough visual indicator of content, but it's no substitute for a lab analysis. Concentrates like CBD hash consist mostly of this resin and therefore contain more cannabinoids per gram than flower material.
Between the content in the material and the amount in the blood lies the method of intake. According to the data from Millar and colleagues, around 31 percent of cannabidiol reaches the bloodstream when smoked, while oral intake yields considerably less. Two flowers with identical percentage figures can therefore lead to very different blood levels.
- The percentage and strain name are listed clearly on the product page, not in the small print.
- The terpene profile shapes smell and taste, myrcene-dominant strains smell earthy, limonene-dominant ones citrusy.
- Strain names say little about aroma and content, as shown in the article on strain names and their meaning.
- A musty smell points to drying too quickly or poor storage, both of which break down terpenes.
In the CBD flowers from I Love Pot overview you'll find the details for each strain. The content of this article is general information and doesn't replace medical or pharmaceutical advice. Our customer service can answer questions about individual strains, you'll find the contact link in the footer of the page.
Sources
- WHO Expert Committee on Drug Dependence: Cannabidiol (CBD) Critical Review Report, Geneva 2018.
- Millar SA et al.: A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans, Frontiers in Pharmacology 2018, doi.org/10.3389/fphar.2018.01365.
- Russo EB: The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis, Frontiers in Plant Science 2019, doi.org/10.3389/fpls.2018.01969.
- Shannon S et al.: Cannabidiol in Anxiety and Sleep, Permanente Journal 2019, doi.org/10.7812/TPP/18-041.
- Suraev AS et al.: Cannabinoid Therapies in the Management of Sleep Disorders, Sleep Medicine Reviews 2020, PubMed ID 32428841.
- Cannabis Act (Konsumcannabisgesetz), § 1 No. 9 KCanG, gesetze-im-internet.de.
Produkte aus dem Artikel
